In an IND-enabling study, intranasal COVI-AMG nAb (STI-2099 or COVI-DROPSTM) very early on decreased COVID-19 disease severity and shortened the duration of the disease in infected hamsters, and ...
Following the conference call, a recording of the webcast will be available on Nasus Pharma’s investor relations website at https://ir.nasuspharma.com/investors/events/.
A recent study published in Pathogens reported that an intranasal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine induced mucosal immune responses in mice. Study: Intranasal ...
Gene therapy for central nervous system (CNS) disorders includes investigation of viral vectors modified to transduce and overexpress proteins with a known neuroprotective function. Viruses can ...
Over the 40-minute period after intranasal insulin administration, elevated standard uptake values were observed in 11 regions. HealthDay News — Intranasal administration of [68 Ga]Ga-NOTA-insulin is ...
Recent advances in drug delivery have led to significant innovations including polymer implants, transdermal patches, and sophisticated oral controlled-release formulations. These technologies, ...
The blood-brain barrier (BBB) prevents the passage of foreign substances from the blood to the brain's extracellular fluid. Several drugs that permeate through the BBB are compromised, and only an ...
Newswise - San Francisco, CA. (August 22, 2011) - A simple new approach to nasal drug administration may allow morphine and other strong pain medications to be targeted directly to the central nervous ...
There's now another reason to love Japan's famous matcha: A study in mice suggests that the green tea powder could reduce the need to sneeze in people with nasal allergies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results